CQUIN’s Advisory Group provides guidance and oversight, and helps to ensure a robust network structure. Members contribute their technical expertise, participate in network events, and help to ensure that the network meets the needs of its diverse members. Ministry of Health members rotate over time to ensure that all countries are represented.
Tsitsi Apollo, MD
Deputy Director, AIDS/STIs, Zimbabwe Ministry of Health and Child Care
Dr. Apollo is a medical doctor and a public health specialist who has been practicing in Zimbabwe’s public health system for over 18 years. She previously worked as the National Tuberculosis Control Programme Manager, and for John Snow Incorporated as an HIV/AIDS Advisor.
She is an active member of the National Medicines Therapeutics Advisory and Policy Committee in Zimbabwe. She participated in the 2013 and 2015 World Health Organization (WHO) Guidelines Development Group for Consolidated ARV Guidelines. She plays an advisory role to the WHO Director General as a member of the Strategic and Technical Advisory Committee for HIV/AIDS and Hepatitis.
Baker Bakashaba, MBChB
Regional project manager, Soroti Region, The AIDS Support Organization (TASO), Uganda
For seven years, Dr. Bakashaba has managed HIV/AIDS programs focusing on design and implementation of facility- and community-based, client-centered projects and health systems strengthening at TASO. He has contributed to the design of community ART models, such as community drug distribution points (CDDP) and community- client-led ART delivery (CCLAD), as well as other national-level differentiated service delivery models.
He is currently the regional project manager for the Accelerating HIV Epidemic Control in Soroti Region project – a regional HIV/AIDS project funded by the President’s Emergency Plan for AIDS Relief (PEPFAR) via the U.S. Centers for Disease Control and Prevention (CDC). Dr. Bakashaba received his Bachelor of Medicine & Surgery Degree from Makerere University in Uganda, and is currently pursuing a Master of Science in project management at the University of Salford, UK.
Executive Director, International Treatment Preparedness Coalition
Ms. Baptiste, has worked with ITPC since 2008, providing technical expertise in monitoring and evaluation, treatment access knowledge building, health financing, accountability, global advocacy, and small grants. Previously she worked at John Snow Inc. in Boston, Massachusetts, mainly on USAID-funded health and development projects across Africa and Asia. She has a Master’s degree in Population and International Health from the Harvard School of Public Health and a BSc in Biology, from Tuskegee University.
Aleny M. Couto, MD
HIV national program chief, Ministry of Health, Mozambique
Dr. Couto is a Mozambican physician with over six years of experience in public health. She is the head of the HIV program at the Ministry of Health in Mozambique, and brings experience in management and implementation of national- and provincial-level health programs. Her work has had a specific focus on HIV/AIDS and the design of policies, country guidelines, and strategic plans following World Health Organization (WHO) guidelines. She has also worked at the district level in primary care, where she implemented a wide range of public health programs. Prior to 2011, Dr. Couto was a clinician treating HIV patients.
Adeniyi Fakoya, MD, FRCP
Senior disease coordinator, HIV, the Global Fund to Fight AIDS, Tuberculosis, and Malaria
Dr. Fakoya is a clinician and specialist in HIV and international health with over 20 years of domestic and international experience in HIV, STI clinical care, service management, and program delivery.
He is currently senior disease coordinator, HIV, at the Global Fund in Geneva. Dr Fakoya has previously held technical, senior management, and research posts working in the UK and internationally. Over the last three years, his team has provided technical support and coordinated partner cooperation resulting in the approval of five billion dollars in Global Fund HIV grant approvals.
His areas of expertise include HIV clinical care and treatment, prevention, and care; ARV scale-up; and the provision of STI clinical services. He has provided technical support to national HIV programs in Africa, Asia, and Latin America. He has sat on a number of national and international advisory committees including those for ARV treatment guidelines, prevention of mother to child transmission guidelines, and sexual and reproductive health.
Nathan Paul Ford, PhD, MPH, FRCPE
Scientific officer, Department of HIV/AIDS and Global Hepatitis Programme, WHO
Dr. Ford is a Fellow of the Royal College of Physicians of Edinburgh. He has published over 400 peer-reviewed publications and is an editorial adviser for the WHO Bulletin, as well as a member of the editorial boards of JAIDS, JIAS, Tropical Medicine and International Health, and Conflict and Health.
Catherine Godfrey, MD, FRACP
Senior Technical Advisor, HIV Care and Treatment, PEPFAR / Office of the Global AIDS Coordinator
Dr. Godfrey is an infectious disease physician with extensive experience in HIV, TB, and STIs. She is the senior technical advisor for adult care and treatment at the Office of the Global HIV AIDS Coordinator. She has published extensively on treatment issues for people living with HIV and last year she received the Constance Wofsy award from the AIDS Clinical Trials Group for her scientific contributions to women’s health.
Peter Godfrey Faussett, BA, MBBS DTM&H, FRCP
Senior Science Adviser, UNAIDS
In his role as Senior Science Advisor, Dr. Faussett focuses on issues ranging from implementation science and vaccine trials to HIV prevention technologies and the intersection with non-communicable diseases.
After training in clinical infectious diseases and molecular genetics, he spent five years leading the Zambian AIDS-related TB (ZAMBART) project, an interdisciplinary collaborative research programme between the London School of Hygiene and Tropical Medicine (LSHTM), Lusaka Urban District Health Management Team, and the University of Zambia. Dr. Faussett spent a year working with the Global Tuberculosis Programme of the World Health Organization, where he was responsible for developing strategies to address the combined epidemic of TB and HIV. He has served as chairman for the Technical Review Panel of the Global Fund against AIDS, Tuberculosis and Malaria, and is a regular member of WHO expert groups. His research interests remain focused on the impact that the HIV epidemic is having on TB control and on interventions to reduce both diseases.
Cordelia Katureebe Mboijana, MBChB
National Coordinator for HIV Care and Treatment, Uganda Ministry of Health AIDS Control Program
Dr. Mboijana is a pediatrician and child health specialist with over 15 years of experience in clinical care, strategic planning, and implementation of programs addressing HIV care and treatment for pregnant women and children with HIV.
She is the coordinator for adolescent HIV services at the Uganda AIDS Control Program, where she develops, reviews, and evaluates adolescent HIV-related program policies. Her work has focused on the rollout of standards of care for adolescents living with HIV across Uganda with the aim of improving care and treatment outcomes of retention and viral load suppression. She is currently a principal investigator for a study to validate a tool to support HIV testing among children and adolescents.
Thomas Minior, MD, MPH
Senior HIV/AIDS Treatment Advisor
United States Agency for International Development
Executive Director for the International Community of Women Living with HIV Eastern Africa
Lillian Mworekois the Executive Director for the International Community of Women Living with HIV Eastern Africa. She is a gender, human rights, and women’s rights defender. Ms. Mworeko is the 2019 CHANGE’s Courageous Change Maker Award Winner; 2016 Uganda HIV&AIDS Leadership Award Winner; 2015 Justice Makers Award Winner; 2014 ICW Inaugural Sisterhood Award Winner; and 2012 Maryhill High School Old Girls Association Award Winner. She served as a member of the Global Community Advisory Board for the ECHO Trial.
Ms. Mworeko is currently the Co-Convener together with UN Women of the Household Settings Thematic Working Group of the Global Partnership for Action to Eliminate all Forms of HIV-related stigma and discrimination. She is a member of the WHO eMTCT Global Validation Advisory Committee.
Catherine Ngugi, MPH, MBChB
National AIDS and STI Control Program
Dr. Ngugi has an MBChB degree from the University of Nairobi, a Post Graduate Diploma in HIV/AIDS Management from the University of Stellenbosch, a Pre-Doctoral Fellowship in HIV Program Management from the University of Nairobi, and an MPH from the University of Aukland.”
Rose Nyirenda, MSc
Director, Department of Health HIV Treatment Unit, Malawi Ministry of Health
Ms. Nyirenda is a community health and inter-professional health care leadership specialist. She is currently the director of the HIV treatment unit at the Ministry of Health in Malawi. Previously, she was the director of Mzuzu Referral Hospital in the northern region of Malawi, heading the Ministry’s Community Health Nursing Program, while also serving as a nurse educator and principal of a nursing college. She was the principal investigator of the EARNEST ART clinical trial, and is currently a member of the National Health Research Ethical Review Board in Malawi. In 2013, Ms. Nyirenda received a special award of recognition on leadership in quality improvement from JHPIEGO. She is currently a PhD candidate at the University of Malawi.
Isaac S. Zulu, MD, MPH
Medical epidemiologist, HIV Care and Treatment Branch of the Division of Global HIV/AIDS and Tuberculosis, CDC Division of Global HIV & TB
Dr. Zulu is an internationally recognized public health leader, clinician, and researcher who has co-authored more than 50 articles in peer-reviewed scientific journals. He is currently a medical epidemiologist on the Adult HIV Treatment Team at the U.S. Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia. He joined the Division of Global HIV/AIDS in October 2012 and currently co-leads the branches’ Service Delivery Unit.
Dr. Zulu is also a member of the Epidemic Control Leadership Team under the Office of the Global AIDS Coordinator (OGAC), where he assists in the development of strategies policy direction to achieve HIV epidemic control in PEPFAR-supported countries. He was previously the chief of the Prevention, Care, and Treatment Branch at the CDC office in Lusaka, Zambia, where he oversaw the scale-up of the country’s HIV treatment program. Dr. Zulu served as clinical chair (2004-2006) and consultant attending physician (1999-2006) in the Department of Internal Medicine, University Teaching Hospital in Lusaka, Zambia. He was an honorary lecturer in internal medicine at the University of Zambia, School of Medicine from 1999-2010.
Dr. Zulu trained as a medical doctor graduating with a Bachelor of Medicine and Surgery from the University of Zambia in 1989. He has specialty training in internal medicine with a Master’s of Medicine in Internal Medicine from the University of Zambia, and a Doctor of Medicine (MD) degree in Gastroenterology from Queen Mary College, University of London, United Kingdom (2008). He obtained his Master’s of Public Health at the University of Alabama at Birmingham in the U.S. in 2002.
Ex Officio Members
Wafaa El-Sadr, MD, MPH, MPA
Dr. Wafaa El-Sadr is the founder and director of ICAP and an international expert in epidemiology and research on the prevention and management of HIV, tuberculosis, and other infectious diseases. For over three decades, she has advocated for families and communities most impacted by HIV and championed a collaborative, multidisciplinary approach to confronting the global epidemic.
Based at Columbia University, she leads ICAP’s portfolio of projects in 24 countries and manages a global team of over 1,000 staff. Under her leadership, ICAP has become a global leader in HIV and health systems strengthening. She is also the director of the Mailman School’s Global Health Initiative (GHI), which mobilizes the University community to address critical challenges in global health.
Dr. El-Sadr is the principal investigator for numerous ICAP-led research initiatives and of the NIH-funded HIV Prevention Trials Network (HPTN). Dr. El-Sadr is also a member of the NIH Fogarty International Center Advisory Board, and in 2009, was appointed to the National Academy of Medicine.
Dr. El-Sadr joined the faculty of Columbia’s College of Physicians and Surgeons in 1988 and become a professor of epidemiology and medicine at the Mailman School of Public Health. In 2013, she was appointed University Professor, Columbia’s highest academic honor. She also holds the Dr. Mathilde Krim-amfAR Chair in Global Health.
Peter Ehrenkranz, MD, MPH
Senior Program Officer for HIV Treatment, Bill & Melinda Gates Foundation
Dr. Peter Ehrenkranz is a Senior Program Officer at the Bill & Melinda Gates Foundation. Prior to joining the Foundation, he worked in Eswatini with the U.S. Centers for Disease Control and Prevention (CDC), first as the PEPFAR Care and Treatment Lead, and later as the Country Director. Before that, he spent two years in Liberia with a joint appointment as senior advisor to the National AIDS Control Program and Medical Director for the Clinton Health Access Initiative (CHAI). Dr. Ehrenkranz has an undergraduate degree in the History of Science and Medicine from Yale, as well as medical and public health degrees from Emory. He trained in internal medicine at the University of Pennsylvania, where he also participated in the Robert Wood Johnson Clinical Scholars Program.
Kigen Bartilol, MBChB
National AIDS and STIs Control Programme
Joseph Cavanaugh, MD
Senior TB technical advisor, Office of Program Quality, PEPFAR
Robert Ferris, DO, MPH
Chief, division of technical leadership & research, Office of HIV/AIDS, USAID
Nomthandazo G. Lukhele, MBCB
National ART coordinator, Swaziland Ministry of Health National AIDS Programme (SNAP)
Rumbidzai P. Matewe
Program manager, Zimbabwe National Network of People Living with HIV (ZNNP+)
Program manager, Zimbabwe National Network of People Living with HIV (ZNNP+)